Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Axillary lymph node count is lower after neoadjuvant chemotherapy.
Neuman H, Carey LA, Ollila DW, Livasy C, Calvo BF, Meyer AA, Kim HJ, Meyers MO, Dees EC, Collichio FA, Sartor CI, Moore DT, Sawyer LR, Frank J, Klauber-DeMore N. Neuman H, et al. Among authors: collichio fa. Am J Surg. 2006 Jun;191(6):827-9. doi: 10.1016/j.amjsurg.2005.08.041. Am J Surg. 2006. PMID: 16720159 Clinical Trial.
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
Dees EC, McKinnon KP, Kuhns JJ, Chwastiak KA, Sparks S, Myers M, Collins EJ, Frelinger JA, Van Deventer H, Collichio F, Carey LA, Brecher ME, Graham M, Earp HS, Serody JS. Dees EC, et al. Cancer Immunol Immunother. 2004 Sep;53(9):777-85. doi: 10.1007/s00262-004-0520-1. Epub 2004 Jun 8. Cancer Immunol Immunother. 2004. PMID: 15185007 Free PMC article.
High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
Klauber-Demore N, Kuzmiak C, Rager EL, Ogunrinde OB, Ollila DW, Calvo BF, Kim HJ, Meyer A, Dees C, Graham M 2nd, Collichio FA, Sartor CI, Metzger R, Carey LA. Klauber-Demore N, et al. Among authors: collichio fa. Am J Surg. 2004 Oct;188(4):386-9. doi: 10.1016/j.amjsurg.2004.06.022. Am J Surg. 2004. PMID: 15474431
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
Stinchcombe TE, Socinski MA, Walko CM, O'Neil BH, Collichio FA, Ivanova A, Mu H, Hawkins MJ, Goldberg RM, Lindley C, Dees EC. Stinchcombe TE, et al. Among authors: collichio fa. Cancer Chemother Pharmacol. 2007 Oct;60(5):759-66. doi: 10.1007/s00280-007-0423-x. Epub 2007 Feb 7. Cancer Chemother Pharmacol. 2007. PMID: 17285317 Free PMC article. Clinical Trial.
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors.
Dees EC, O'Neil BH, Lindley CM, Collichio F, Carey LA, Collins J, Riordan WJ, Ivanova A, Esseltine D, Orlowski RZ. Dees EC, et al. Cancer Chemother Pharmacol. 2008 Dec;63(1):99-107. doi: 10.1007/s00280-008-0716-8. Epub 2008 Mar 8. Cancer Chemother Pharmacol. 2008. PMID: 18327587 Free PMC article. Clinical Trial.
79 results